百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02315 百奥赛图-B

已收盘 01-06 16:08:09

7.660

-0.450

-5.55%

最高7.980	最低7.520	成交量2.75万
今开7.800	昨收8.110	日振幅5.67%
总市值30.59亿	流通市值8.50亿	总股本3.99亿
成交额20.96万	换手率0.02%	流通股本1.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":7.66,"timestamp":1736150889013,"preClose":8.11,"halted":0,"volume":27500,"delay":0,"floatShares":111000000,"shares":399398420,"eps":-1.0186867272762612,"marketStatus":"已收盘","change":-0.45,"latestTime":"01-06 16:08:09","open":7.8,"high":7.98,"low":7.52,"amount":209645,"amplitude":0.05672,"askPrice":7.7,"askSize":4500,"bidPrice":7.51,"bidSize":10000,"shortable":0,"etf":0,"ttmEps":-0.6486658157377101,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1736213400000},"marketStatusCode":5,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":8.11,"openAndCloseTimeList":[[1736127000000,1736136000000],[1736139600000,1736150400000]],"volumeRatio":0.333787,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"2501020204","title":"【百奥赛图-B(02315.HK)拟为股份奖励计划进一步购买不超过5000万港元的股份】百奥赛图-B(02315.HK)公布，2024年，公司经营业绩大幅提升。在上半年度经营活动现金流量金额已经转正，亏损大幅收窄的基础上，全年有望实现盈亏平衡。同时，董事会及管理团队对公司2025年经营业绩以及未来发展前景充满信心。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501020204","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501020204?lang=zh_cn&edition=full","pubTime":"2025-01-06 16:38","pubTimestamp":1736152704,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315.HK)公布，2024年，公司经营业绩大幅提升。在上半年度经营活动现金流量金额已经转正，亏损大幅收窄的基础上，全年有望实现盈亏平衡。同时，董事会及管理团队对公司2025年经营业绩以及未来发展前景充满信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/06163847154677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2501078444","title":"百奥赛图-B(02315)拟为股份奖励计划进一步购买不超过5000万港元的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2501078444","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501078444?lang=zh_cn&edition=full","pubTime":"2025-01-06 16:35","pubTimestamp":1736152556,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315)公布，2024年，公司经营业绩大幅提升。在上半年度经营活动现金流量金额已经...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_31.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_31.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1233764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2501473254","title":"百奥赛图-B盘中异动 早盘股价大跌6.17%报7.610港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501473254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501473254?lang=zh_cn&edition=full","pubTime":"2025-01-06 11:07","pubTimestamp":1736132838,"startTime":"0","endTime":"0","summary":"2025年01月06日早盘11时07分，百奥赛图-B股票出现波动，股价急速下跌6.17%。截至发稿，该股报7.610港元/股，成交量3000股，换手率0.00%，振幅2.34%。资金方面，该股资金流入0港元，流出1.151万港元。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.41%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106110719ab9fe229&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106110719ab9fe229&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2500665481","title":"IPO雷达｜百奥赛图募资额缩水7亿元 港股股价跌近七成 实控人高负债借新还旧","url":"https://stock-news.laohu8.com/highlight/detail?id=2500665481","media":"读创客户端","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500665481?lang=zh_cn&edition=full","pubTime":"2025-01-04 17:56","pubTimestamp":1735984593,"startTime":"0","endTime":"0","summary":"截至2024年6月30日，百奥赛图货币资金余额为4.11亿元，可以覆盖短期有息负债规模。实际控制人负有大额债务据悉，截至招股说明书签署日，沈月雷、倪健合计直接或间接控制发行人27.1921%表决权，为百奥赛图共同控股股东、实际控制人。百奥赛图提示称，上述实际控制人负债到期后，如实际控制人不能与债权人达成合理的债务展期计划或按期偿还负债，则届时实际控制人持有的公司股份可能被债权人要求冻结、处置或实际控制人受到行政处罚。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104180427985ae92a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104180427985ae92a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","HSTECH","07226","HSCEI","BK1161"],"gpt_icon":0},{"id":"2500139749","title":"百奥赛图-B盘中异动 早盘大幅下跌5.78%报7.820港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500139749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500139749?lang=zh_cn&edition=full","pubTime":"2025-01-03 10:20","pubTimestamp":1735870810,"startTime":"0","endTime":"0","summary":"2025年01月03日早盘10时20分，百奥赛图-B股票出现异动，股价快速跳水5.78%。截至发稿，该股报7.820港元/股，成交量8000股，换手率0.01%，振幅3.86%。资金方面，该股资金流入0港元，流出6.261万港元。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.24%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010310201095f73922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010310201095f73922&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2495656095","title":"百奥赛图-B盘中异动 早盘急速跳水5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495656095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495656095?lang=zh_cn&edition=full","pubTime":"2024-12-30 10:59","pubTimestamp":1735527569,"startTime":"0","endTime":"0","summary":"2024年12月30日早盘10时59分，百奥赛图-B股票出现波动，股价快速跳水5.33%。截至发稿，该股报8.000港元/股，成交量3.6万股，换手率0.03%，振幅7.10%。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.14%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230105929ab97697c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230105929ab97697c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2493440667","title":"百奥赛图-B盘中异动 早盘大幅上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493440667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493440667?lang=zh_cn&edition=full","pubTime":"2024-12-24 10:01","pubTimestamp":1735005707,"startTime":"0","endTime":"0","summary":"2024年12月24日早盘10时01分，百奥赛图-B股票出现波动，股价快速拉升5.08%。截至发稿，该股报8.900港元/股，成交量6000股，换手率0.01%，振幅4.84%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予卖出建议，无券商给予买入、持有建议。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.20%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224100147984d47ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224100147984d47ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2492941582","title":"创新药概念多数上扬 圣诺医药(02257)涨11.56% 机构指医药创新是医药增长的核心动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2492941582","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492941582?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:55","pubTimestamp":1734486946,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念多数上扬，圣诺医药 涨11.56%，百奥赛图涨9.68%，歌礼制药涨7.98%，绿竹生物涨4.73%，再鼎医药涨4.41%，康诺亚涨1.34%，中国生物制药涨0.95%，信达生物涨0.69%银河证券表示，1）医药创新是医药增长的核心动力。对于医药板块， 在“医保+商保”模式不断推进、政策支持等因素驱动下，行业规模有望进一步扩大。“医保+商保”模式打开健康险空间，创新药发展空间更大。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949850","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02480","02257","159938","01672","09939","BK1521","BK1587","BK1515","BK1583","BK1588","BK1589","09688","02162","02315","BK1161","LU1969619763.USD","LU2488822045.USD","BK1574","159992","01177","LU2328871848.SGD","01801","06978","BK1191"],"gpt_icon":0},{"id":"2492983949","title":"百奥赛图-B盘中异动 快速拉升9.68%报8.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492983949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492983949?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:41","pubTimestamp":1734486061,"startTime":"0","endTime":"0","summary":"2024年12月18日早盘09时41分，百奥赛图-B股票出现异动，股价急速上涨9.68%。截至发稿，该股报8.500港元/股，成交量1000股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出8500港元。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，百奥赛图-B、帝王国际投资、绿竹生物-B涨幅较大，振幅较大的相关个股有永泰生物-B、帝王国际投资、晶泰控股-P，振幅分别为14.23%、5.88%、5.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218094103984c9ae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218094103984c9ae6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2491662362","title":"百奥赛图宣布Adcendo ApS行使抗体选择权以加速ADC开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2491662362","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491662362?lang=zh_cn&edition=full","pubTime":"2024-12-16 18:00","pubTimestamp":1734343200,"startTime":"0","endTime":"0","summary":"Adcendo行使选择权，利用百奥赛图的全人抗体进一步扩展其ADC管线，开发针对高度未满足医疗需求的癌症的新型疗法。百奥赛图董事长兼CEO沈月雷博士表示：\"我们非常高兴能够通过百奥赛图先进的抗体发现平台，支持Adcendo在创新ADC药物领域的开发计划。结合Adcendo在ADC领域的丰富经验，我们相信此次合作将加速创新疗法的研发，造福全球患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4580315_ZH80315_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4231","02315","ADC","BK4080","BK1161"],"gpt_icon":0},{"id":"2491968185","title":"百奥赛图-B盘中异动 急速拉升6.18%报8.420港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491968185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491968185?lang=zh_cn&edition=full","pubTime":"2024-12-16 09:46","pubTimestamp":1734313615,"startTime":"0","endTime":"0","summary":"2024年12月16日早盘09时46分，百奥赛图-B股票出现波动，股价大幅拉升6.18%。截至发稿，该股报8.420港元/股，成交量1.7万股，换手率0.02%，振幅6.31%。资金方面，该股资金流入2.462万港元，流出8.4625万港元。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，东曜药业-B、云康集团、百奥赛图-B涨幅较大，振幅较大的相关个股有创胜集团-B、加科思-B、东曜药业-B，振幅分别为18.03%、11.59%、9.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216094655ab7b037f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216094655ab7b037f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2491507314","title":"百奥赛图-B(02315)上涨6.89%，报7.91元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491507314","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491507314?lang=zh_cn&edition=full","pubTime":"2024-12-13 14:57","pubTimestamp":1734073029,"startTime":"0","endTime":"0","summary":"12月13日，百奥赛图-B(02315)盘中上涨6.89%，截至14:57，报7.91元/股，成交100.62万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2024年中报，百奥赛图-B营业总收入4.1亿元、净利润-5067.3万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/13145746352418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2491392511","title":"百奥赛图-B盘中异动 临近午盘快速拉升5.41%报7.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491392511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491392511?lang=zh_cn&edition=full","pubTime":"2024-12-13 11:30","pubTimestamp":1734060629,"startTime":"0","endTime":"0","summary":"2024年12月13日临近午盘11时30分，百奥赛图-B股票出现波动，股价急速上涨5.41%。截至发稿，该股报7.800港元/股，成交量5.6万股，换手率0.05%，振幅6.62%。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，北海康成-B、圣诺医药-B、百奥赛图-B涨幅较大，振幅较大的相关个股有晶泰控股-P、圣诺医药-B、思路迪医药股份，振幅分别为35.55%、27.53%、22.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121311302995e955af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121311302995e955af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2490116884","title":"百奥赛图-B(02315)上涨8.18%，报7.27元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490116884","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490116884?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:24","pubTimestamp":1733901842,"startTime":"0","endTime":"0","summary":"12月11日，百奥赛图-B(02315)盘中上涨8.18%，截至15:24，报7.27元/股，成交113.34万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2024年中报，百奥赛图-B营业总收入4.1亿元、净利润-5067.3万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/11152446252020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2490000865","title":"百奥赛图-B盘中异动 股价大涨5.06%报7.060港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490000865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490000865?lang=zh_cn&edition=full","pubTime":"2024-12-11 10:20","pubTimestamp":1733883628,"startTime":"0","endTime":"0","summary":"2024年12月11日早盘10时20分，百奥赛图-B股票出现异动，股价大幅上涨5.06%。截至发稿，该股报7.060港元/股，成交量7000股，换手率0.01%，振幅3.87%。资金方面，该股资金流入3.4905万港元，流出3450港元。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，北海康成-B、百奥赛图-B、药明生物涨幅较大，振幅较大的相关个股有北海康成-B、晶泰控股-P、思路迪医药股份，振幅分别为45.77%、10.62%、9.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121110202895e8d2a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121110202895e8d2a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2490345920","title":"百奥赛图-B盘中异动 股价大涨5.14%报6.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490345920","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490345920?lang=zh_cn&edition=full","pubTime":"2024-12-10 09:52","pubTimestamp":1733795552,"startTime":"0","endTime":"0","summary":"2024年12月10日早盘09时52分，百奥赛图-B股票出现波动，股价急速拉升5.14%。截至发稿，该股报6.950港元/股，成交量3.2万股，换手率0.03%，振幅5.14%。资金方面，该股资金流入12.7385万港元，流出4.081万港元。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.37%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210095232984ae3cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210095232984ae3cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2490713620","title":"百奥赛图-B盘中异动 大幅上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490713620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490713620?lang=zh_cn&edition=full","pubTime":"2024-12-09 13:26","pubTimestamp":1733721982,"startTime":"0","endTime":"0","summary":"2024年12月09日下午盘13时26分，百奥赛图-B股票出现异动，股价急速上涨5.56%。截至发稿，该股报6.450港元/股，成交量8.25万股，换手率0.07%，振幅7.36%。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.78%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120913262298e6705b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120913262298e6705b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2489002501","title":"百奥赛图-B(02315)上涨5.54%，报6.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489002501","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489002501?lang=zh_cn&edition=full","pubTime":"2024-12-05 14:32","pubTimestamp":1733380320,"startTime":"0","endTime":"0","summary":"12月5日，百奥赛图-B(02315)盘中上涨5.54%，截至14:32，报6.1元/股，成交114.45万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2024年中报，百奥赛图-B营业总收入4.1亿元、净利润-5067.3万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/05143246045199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2489143454","title":"百奥赛图-B盘中异动 下午盘急速拉升5.02%报6.070港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489143454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489143454?lang=zh_cn&edition=full","pubTime":"2024-12-05 14:16","pubTimestamp":1733379360,"startTime":"0","endTime":"0","summary":"2024年12月05日下午盘14时16分，百奥赛图-B股票出现波动，股价急速拉升5.02%。截至发稿，该股报6.070港元/股，成交量14.5万股，换手率0.13%，振幅4.67%。资金方面，该股资金流入39.921万港元，流出42.7595万港元。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.98%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205141600a1d58cf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205141600a1d58cf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2486773519","title":"百奥赛图-B盘中异动 下午盘股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486773519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486773519?lang=zh_cn&edition=full","pubTime":"2024-11-25 14:35","pubTimestamp":1732516547,"startTime":"0","endTime":"0","summary":"2024年11月25日下午盘14时35分，百奥赛图-B股票出现波动，股价大幅拉升5.47%。截至发稿，该股报5.980港元/股，成交量7.2万股，换手率0.06%，振幅4.23%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予卖出建议，无券商给予买入、持有建议。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.43%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112514354798e4458b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112514354798e4458b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":-0.0402},{"period":"1month","weight":0.4031},{"period":"3month","weight":-0.1816},{"period":"6month","weight":0.0505},{"period":"1year","weight":-0.3021},{"period":"ytd","weight":-0.0459}],"compareEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":0.0009},{"period":"3month","weight":-0.1309},{"period":"6month","weight":0.1102},{"period":"1year","weight":0.1871},{"period":"ytd","weight":-0.0149}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图（北京）医药科技股份有限公司是一家主要从事药物开发业务及临床前研究的公司。该公司通过五个分部开展业务。基因编辑服务分部提供基于动物和细胞的定制化基因编辑服务。临床前药理药效评估分部提供用于药物疗效和毒性评估的临床前药理学服务。模式动物销售分部培育和销售外用和内用模式动物。抗体开发分部利用抗体发现平台识别有可能成为候选药物的抗体。创新药开发分部研发创新药，专注肿瘤学和自身免疫性疾病治疗。","exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}